Rick Sax, MD
Senior Advisor
Rick is a 30-year veteran of the pharmaceutical industry, having held senior positions in Clinical Development at Merck & Co. and AstraZeneca. His career has included leading cardiovascular drug development at Merck, and leadership roles in the U.S. Business, Global Medical Sciences, and New Opportunities at AstraZeneca. At AstraZeneca he also helped lead the effort to transform Clinical Development, focusing on improving program and protocol design and how this linked to operational productivity.
Rick joined Quintiles in 2011, where he oversaw Biostatistics, Medical Writing, Global Regulatory Affairs, Safety Knowledge & Reporting, and global Laboratory operations. He formed the Center for Integrated Drug Development – Quintile’s home for clinical program and trial design with its enabling technology platform, Infosario Design®. In 2014 he became a Managing Director in QuintilesIMS (now IQVIA) Consulting Services and then a Senior Vice-President in IQVIA Design & Delivery Innovation, leading the Strategic Drug Development business unit. This unit supports biopharma companies to design integrated development, regulatory, and commercial strategies for their assets, as well as due diligence activities.
He also was one of the founding leaders of IQVIA’s Cell and Gene Therapy group. Rick now is the Managing Director of Pharma Design Solutions, Ltd., his own consultancy practice, supporting senior biopharmaceutical executives with their corporate and organizational aspirations, as well as technology companies interested in improving R&D productivity in the pharmaceutical industry.